Cargando…

Ceftriaxone-Induced Immune Hemolytic Anemia: In Vitro Reversal with Peptide Inhibitor of Complement C1 (PIC1)

We report a case of ceftriaxone-induced immune hemolytic anemia in a 10-year-old with chronic active Epstein–Barr virus disease and hemophagocytic lymphohistiocytosis. After chemotherapy, she became febrile and received ceftriaxone. She rapidly developed respiratory failure and anemia. Her direct an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cunnion, Kenji M., Feagin, Lisa M., Chicella, Michael F., Kaszowski, Cortney L., Hair, Pamela S., Price, Jessica, Owen, William C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374879/ https://www.ncbi.nlm.nih.gov/pubmed/30838143 http://dx.doi.org/10.1155/2019/4105653

Ejemplares similares

Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)
por: Hair, Pamela S., et al.
Publicado: (2017)

Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants
por: Hair, Pamela S., et al.
Publicado: (2019)

Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT)
por: Gregory Rivera, Magdielis, et al.
Publicado: (2018)

Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats
por: Sharp, Julia A., et al.
Publicado: (2015)

Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin
por: Hair, Pamela S., et al.
Publicado: (2017)

Ceftriaxone-Induced Immune Hemolytic Anemia
por: Singh, Anil, et al.
Publicado: (2020)

Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1
por: Hair, Pamela S., et al.
Publicado: (2018)

Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease and the Role of the Classical Complement Pathway: A Case Report
por: Hair, Pamela S., et al.
Publicado: (2021)

Ceftriaxone-Induced Hemolytic Anemia in a Jehovah’s Witness
por: Tasch, James, et al.
Publicado: (2017)

Ceftriaxone induced immune hemolytic anemia with disseminated intravascular coagulation
por: Shrimali, Jigar D., et al.
Publicado: (2013)

An Uncommon Incidence of Drug-Induced Immune Hemolytic Anemia Secondary to Ceftriaxone
por: Sharma, Aishwarya, et al.
Publicado: (2021)

Role of Complement in Autoimmune Hemolytic Anemia
por: Berentsen, Sigbjørn
Publicado: (2015)

Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model
por: Kumar, Parvathi, et al.
Publicado: (2021)

Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature
por: Leicht, Hans Benno, et al.
Publicado: (2018)

Novel insights into the treatment of complement-mediated hemolytic anemias
por: Berentsen, Sigbjørn, et al.
Publicado: (2019)

Hyperglycemia Inhibits Complement-Mediated Immunological Control of S. aureus in a Rat Model of Peritonitis
por: Mauriello, Clifford T., et al.
Publicado: (2014)

Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice
por: Bhutta, Maimoona S., et al.
Publicado: (2021)

Therapeutic Hypothermia Inhibits the Classical Complement Pathway in a Rat Model of Neonatal Hypoxic-Ischemic Encephalopathy
por: Shah, Tushar A., et al.
Publicado: (2021)

Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease
por: Sass, Laura A., et al.
Publicado: (2015)

C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia
por: de Boer, Esther C. W., et al.
Publicado: (2023)

Peptide Inhibitor of Complement C1, a Novel Suppressor of Classical Pathway Activation: Mechanistic Studies and Clinical Potential
por: Sharp, Julia A., et al.
Publicado: (2014)

Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity
por: Hair, Pamela S., et al.
Publicado: (2017)

Ceftriaxone-induced immune hemolytic anemia in a case with large vestibular aqueduct syndrome after cochlear implant
por: Wang, Yu, et al.
Publicado: (2019)

An Unusual Case of Hemolytic Anemia Reversed with Liver Transplantation
por: Katiyar, Vatsala, et al.
Publicado: (2022)

Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway
por: Shah, Tushar A, et al.
Publicado: (2014)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Staphylococcus aureus Surface Protein SdrE Binds Complement Regulator Factor H as an Immune Evasion Tactic
por: Sharp, Julia A., et al.
Publicado: (2012)

Peptide inhibition of neutrophil-mediated injury after in vivo challenge with supernatant of Pseudomonas aeruginosa and immune-complexes
por: Enos, Adrianne, et al.
Publicado: (2021)

PIC BASIC projects: 30 projects using PIC BASIC and PIC BASIC PRO
por: Ibrahim, Dogan
Publicado: (2006)

Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation
por: Chen, Jin Y., et al.
Publicado: (2020)

Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy
por: Berentsen, Sigbjørn, et al.
Publicado: (2015)

Pulmonary hypertension in hemolytic anemias
por: Wahl, Shannon, et al.
Publicado: (2010)

About Microangiopathic Hemolytic Anemia
por: Özsoylu, Şinasi
Publicado: (2015)

Thymoma with Autoimmune Hemolytic Anemia
por: Suzuki, Kensuke, et al.
Publicado: (2014)

Ibuprofen-Induced Hemolytic Anemia
por: Barbaryan, Aram, et al.
Publicado: (2013)

Metformin-Induced Hemolytic Anemia
por: Kirkiz, Serap, et al.
Publicado: (2014)

Hemolytic Anemias: Autoimmune and Beyond
por: Krishnadasan, Ravi
Publicado: (2021)

Hemolytic anemia in COVID-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Vancomycin-Induced Hemolytic Anemia
por: Siddiqui, Fakeha, et al.
Publicado: (2023)

RLS-0071 Moderated Elevated Myeloperoxidase Level and Activity in an Asymptomatic Subject in Clinical Trial RLS-0071-101
por: Goss, Jessica M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mhpo0aor1nif3pqjkvop61qpe4